Barclays lowered the firm’s price target on Ryan Specialty (RYAN) to $39 from $41 and keeps an Overweight rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RYAN:
- Wells downgrades Ryan Specialty to Equal Weight on below peer growth
- Ryan Specialty downgraded to Equal Weight from Overweight at Wells Fargo
- Ryan Specialty reports Q2 adjusted EPS 47c, consensus 43c
- Ryan Specialty sees FY26 organic revenue growth rate in mid-single digits
- Ryan Specialty posts strong first-quarter revenue and earnings